World Investment Advisors purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 764 shares of the biotechnology company's stock, valued at approximately $454,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its position in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after buying an additional 65,097 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after buying an additional 812,337 shares during the last quarter. Norges Bank bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $482,081,000. Finally, GQG Partners LLC purchased a new position in Axon Enterprise in the 4th quarter worth approximately $478,349,000. Institutional investors own 79.08% of the company's stock.
Axon Enterprise Price Performance
Shares of Axon Enterprise stock traded up $16.73 during trading on Friday, reaching $567.98. 516,424 shares of the stock traded hands, compared to its average volume of 815,515. The business has a fifty day simple moving average of $567.07 and a two-hundred day simple moving average of $560.54. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a market capitalization of $43.52 billion, a price-to-earnings ratio of 146.77, a P/E/G ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on AXON. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price on the stock. Barclays restated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC restated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $626.45.
Get Our Latest Stock Report on AXON
Insiders Place Their Bets
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.